Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.

[1]  S. Neubauer,et al.  Incidence, predictors, and significance of abnormal cardiac enzyme rise in patients treated with bypass surgery in the Arterial Revascularization Therapies Study (ARTS). , 2002, Circulation.

[2]  B. Chaitman,et al.  Increased mortality after coronary artery bypass graft surgery is associated with increased levels of postoperative creatine kinase-myocardial band isoenzyme release: results from the GUARDIAN trial. , 2001, Journal of the American College of Cardiology.

[3]  Patrick W. Serruys,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease , 2001 .

[4]  Mitchell W. Krucoff,et al.  Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.

[5]  R. Kim,et al.  Visualization of Discrete Microinfarction After Percutaneous Coronary Intervention Associated With Mild Creatine Kinase-MB Elevation , 2001, Circulation.

[6]  F Unger,et al.  Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. , 2001, The New England journal of medicine.

[7]  F. Welt,et al.  Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the Department of Veterans Affairs Cooperative Study #385, th , 2001, Journal of the American College of Cardiology.

[8]  M. Czerny,et al.  Inflammatory response and myocardial injury following coronary artery bypass grafting with or without cardiopulmonary bypass. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  J. Maessen,et al.  Peri-operative myocardial tissue injury and the release of inflammatory mediators in coronary artery bypass graft patients. , 2000, Cardiovascular research.

[10]  E. Topol,et al.  Recognition of the importance of embolization in atherosclerotic vascular disease. , 2000, Circulation.

[11]  M. Carrier,et al.  Troponin levels in patients with myocardial infarction after coronary artery bypass grafting. , 2000, The Annals of thoracic surgery.

[12]  R. Califf,et al.  Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: results from a multicentre randomised trial , 1999, The Lancet.

[13]  A. Syed,et al.  Antegrade crystalloid cardioplegia vs antegrade/retrograde cold and tepid blood cardioplegia in CABG. , 1999, The Annals of thoracic surgery.

[14]  R. Califf,et al.  Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. , 1999, Circulation.

[15]  R. Califf,et al.  Clinical outcomes after detection of elevated cardiac enzymes in patients undergoing percutaneous intervention , 1999 .

[16]  C. Hanet,et al.  The significance of myocardial enzyme release following multivessel stenting or CABG in the ARTS trial , 1999 .

[17]  P. Fiorina,et al.  Cardiac Troponin T to evaluate myocardial protection via intermittent cold blood or continuous warm blood cardioplegia in coronary artery bypass grafting. , 1998, The Journal of cardiovascular surgery.

[18]  D. Chatel,et al.  Cardiac troponin I in diagnosis of perioperative myocardial infarction after cardiac surgery. , 1998, Journal of cardiothoracic and vascular anesthesia.

[19]  R. Califf,et al.  Myonecrosis after revascularization procedures. , 1998, Journal of the American College of Cardiology.

[20]  H. Arendrup,et al.  Significance and management of early graft failure after coronary artery bypass grafting: feasibility and results of acute angiography and re-re-vascularization. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  M. Gotsman,et al.  Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation. , 1997, Journal of the American College of Cardiology.

[22]  David P Miller,et al.  Long-term Protection From Myocardial Ischemic Events in a Randomized Trial of Brief Integrin β3 Blockade With Percutaneous Coronary Intervention , 1997 .

[23]  David P Miller,et al.  Long-term protection from myocardial ischemic events in a randomized trial of brief integrin beta3 blockade with percutaneous coronary intervention. EPIC Investigator Group. Evaluation of Platelet IIb/IIIa Inhibition for Prevention of Ischemic Complication. , 1997, JAMA.

[24]  L Chiariello,et al.  A comparison of coronary-artery stenting with angioplasty for isolated stenosis of the proximal left anterior descending coronary artery. , 1997, The New England journal of medicine.

[25]  R. Bonow,et al.  Prognostic implication of creatine kinase elevation following elective coronary artery interventions. , 1997, JAMA.

[26]  E. Topol,et al.  The myth of the myocardial 'infarctlet' during percutaneous coronary revascularization procedures. , 1996, Circulation.

[27]  James T. Willerson,et al.  Appointment of New Associate Editor for Circulation , 1996 .

[28]  E. Antman,et al.  Current incidence and determinants of perioperative myocardial infarction in coronary artery surgery. , 1996, American heart journal.

[29]  W J Keon,et al.  Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. , 1996, Journal of the American College of Cardiology.

[30]  Robert L. Frye,et al.  Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, The New England journal of medicine.

[31]  E. Topol,et al.  Defining the appropriate threshold of creatine kinase elevation after percutaneous coronary interventions. , 1996, American heart journal.

[32]  M. Kutner,et al.  A Randomized Trial Comparing Coronary Angioplasty with Coronary Bypass Surgery , 1994 .

[33]  C. Hamm,et al.  A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German Angioplasty Bypass Surgery Investigation (GABI) , 1994, The New England journal of medicine.

[34]  M. Kutner,et al.  A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory Angioplasty versus Surgery Trial (EAST) , 1994, The New England journal of medicine.

[35]  Joy,et al.  Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. , 1993, Lancet.

[36]  RITA-2 trial participants.  Coronary angioplasty versus coronary artery bypass surgery: the Randomised Intervention Treatment of Angina (RITA) trial , 1993, The Lancet.

[37]  B. Jugdutt,et al.  Functional impact of remodeling during healing after non-Q wave versus Q wave anterior myocardial infarction in the dog. , 1992, Journal of the American College of Cardiology.

[38]  A. Neufang,et al.  Diagnosis of perioperative myocardial necrosis following coronary artery surgery--a reappraisal of isoenzyme analysis. , 1990, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[39]  J. Hochman,et al.  Limitation of myocardial infarct expansion by reperfusion independent of myocardial salvage. , 1987, Circulation.

[40]  W. C. Sheldon,et al.  Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. , 1986, The New England journal of medicine.